Lauren Charles, a chief data scientist at PNNL, showcased the vital research coming out of her program at The National Academies Forum workshop in Washington, D.C., January 15–16, 2025.

PNNL chemical engineer Mariefel Olarte shares passion for mentoring students and the next-generation workforce.

Francesca Pierobon holds a joint appointment with UW and WSU to advance low-carbon technologies.

PNNL biodefense experts seek to identify, understand and mitigate the risks of biological pathogens—whether naturally occurring or intentionally created—so steps can be taken to prepare and respond.

Researchers will explore climate, pathogens and energy-efficient microelectronics using 3 million node hours on the nation’s supercomputers.

Research at PNNL and the University of Texas at El Paso are addressing computational challenges of thinking beyond the list and developing bioagent-agnostic signatures to assess threats.

Beyond melting ice and higher temperatures: On Earth Day, scientists consider how climate change will affect national security.

Americans produce enough waste every year to replace up to a quarter of the country’s jet fuel with sustainable alternatives, new research shows.

Scott Baker, the Functional and Systems Biology Group leader at PNNL, has been named to the American Institute for Medical and Biological Engineering's Class of 2024 Fellows.

An initiative from Washington State University and Snohomish County leaders is aiming to make Paine Field a nexus for testing and improving sustainable aviation fuels made from non-petroleum materials.

PNNL-developed catalytic process and catalyst to upgrade ethanol to sustainable aviation fuel wins American Chemical Society award.

Microbes that were previously frozen in soils are becoming more active. This study demonstrates the diverse RNA viral communities found in thawed permafrost.

Scientists can detect the virus that causes COVID-19 by using a bubble that spills its contents like a piñata when encountering the virus.

A PNNL research team has been recognized by the American Chemical Society with its Award for Affordable Green Chemistry.

A process developed at PNNL that converts biomass and waste into a chemical intermediate or into gasoline, diesel, and jet fuel is available for commercial licensing.

TransMED analyzes patient data from similar diseases across multiple sources to understand COVID-19 patient outcome risk factors.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

PNNL scientists publish paper and host workshops to share threat-agnostic vision for biodefense.

PNNL chief scientist Jonathan Male has been named co-director of the joint Washington State University-PNNL Bioproducts Institute.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.